Biomarkers in Cancer Detection and Monitoring of Therapeutics

Volume 2: Diagnostic and Therapeutic Applications

Ranbir Chander Sobti, Masatoshi Watanabe, Aastha Sobti

• Publisher: Academic Press
• Year: 2023
• Print ISBN: 9780323951142
• eBook ISBN: 9780323951159
• Topic: Business
• Subtopic: Business intelligence
• Index: Business

Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case. This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research. - Provides up-to-date information on current molecular biomarkers research for cancer - Presents new diagnostic techniques using biomarkers that can leverage quicker results that can be essential for patient's survivorship - Discusses several novel therapeutics applied to specific cancer types, such as head and neck, oral, GI tract, breast, lung and hepatocellular carcinomas

Table of contents

• Cover
• Front Matter
• Table of Contents
• Copyright
• Contributors
• Preface
• List of Illustrations
• List of Tables
• Chapter One : Oral squamous cell carcinoma
• Chapter Two : Genetic predisposition and pathophysiology of oral squamous cell carcinoma
• Chapter Three : Molecular biomarkers in gastric cancer
• Chapter Four : Recent advancement in molecular markers of pancreatic cancer
• Chapter Five : Molecular biomarkers in pancreatic ductal adenocarcinoma
• Chapter Six : Biomarkers in endocrine diseases
• Chapter Seven : Cancer immunotherapy-associated endocrine complications and treatment strategies
• Chapter Eight : Shared and distinct aspects of hematopoietic malignancies such as leukemia and lymphoma
• Chapter Nine : Molecular diagnosis, drivers, and treatment modalities for chronic lymphocytic leukemia
• Chapter Ten : Myelodysplastic syndrome: A challenging entity
• Chapter Eleven : Multiple myeloma
• Chapter Twelve : Role of biomarkers in assessing response to immune checkpoint inhibitors in cancer treatment
• Chapter Thirteen : Molecular biomarkers in prostate cancer
• Chapter Fourteen : Biomarkers in endometrial and cervical cancer
• Chapter Fifteen : Skin cancer biology and its biomarkers: Recent trends and prospective
• Chapter Sixteen : Genetics of neuronal and glioneuronal cancers
• Chapter Seventeen : Therapeutic potential of melatonin in glioblastoma: Current knowledge and future prospects
• Chapter Eighteen : Genotype influenced pharmacokinetics of anticancer medicine: A connecting link
• Chapter Nineteen : Emergence of metal-based anticancer therapeutics: A promising perspective
• Chapter Twenty : Nanoparticles for drug delivery in cancer therapy
• Chapter Twenty-One : Near-infrared (NIR) responsive nanomaterial–liposome nanohybrids for cancer photothermal therapy
• Chapter Twenty-Two : Anticancer activities of macromolecules of marine origin: Clinical evidence
• Chapter Twenty-Three : Therapeutic potential of microalgae and their prospects in targeted delivery in cancer management
• Chapter Twenty-Four : Prospects of mangrove-derived phytochemicals in cancer research
• Chapter Twenty-Five : Impact of pesticides on immune-endocrine disorders and its relationship to cancer development
• Index
• A